RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announces that a leading, independent research firm, Everest Group, has recognized IQVIA as a Leader in its Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix® Assessment 2024 survey, which measures both market impact and delivery effectiveness..

RESEARCH TRIANGLE PARK，N.C.-（商业新闻短讯）--IQVIA™（纽约证券交易所：IQV）今天宣布，一家领先的独立研究公司Everest Group已认可IQVIA为其生命科学监管和医疗事务运营峰值矩阵®评估2024年调查的领导者，该调查同时衡量市场影响和交付效率。。

The Everest Group report highlights IQVIA’s focus on innovation and its comprehensive portfolio of solutions that accelerates drug development from molecule to market. IQVIA partners with customers to plan, generate and disseminate trustworthy clinical and medical evidence which drives the right stakeholder dialogue throughout the asset lifecycle to advance regulatory and healthcare decision making that improves patient outcomes..

珠穆朗玛峰集团的报告强调了IQVIA对创新的关注及其全面的解决方案组合，这些解决方案加速了药物从分子到市场的发展。IQVIA与客户合作，计划、生成和传播值得信赖的临床和医学证据，从而在整个资产生命周期中推动正确的利益相关者对话，以推进监管和医疗决策，从而改善患者的预后。。

A strong global footprint, along with AI-enabled technology and analytic solutions allow IQVIA to ease the burden of regulatory complexities and compliance demands in different geographies for regulatory customers. IQVIA’s end-to-end solutions enable medical affairs customers to manage and curate the richness of data coming into their organization, transforming evidence into insights that can enable actionable change.

强大的全球足迹，以及支持人工智能的技术和分析解决方案，使IQVIA能够减轻监管客户在不同地区的监管复杂性和法规遵从性需求的负担。IQVIA的端到端解决方案使医疗事务客户能够管理和管理进入其组织的丰富数据，将证据转化为见解，从而实现可行的变革。

As with all IQVIA AI-powered solutions, the AI capabilities in IQVIA’s medical affairs and regulatory solutions are grounded in IQVIA Healthcare-grade AI™ – AI engineered to meet the level of precision, speed and trust required for life sciences and healthcare..

与所有以IQVIA人工智能为动力的解决方案一样，IQVIA医疗事务和监管解决方案中的人工智能功能都以IQVIA Healthcare grade AI™为基础，该AI旨在满足生命科学和医疗保健所需的精确度、速度和信任度。。

“IQVIA is honored to be recognized for its role in enabling our medical affairs and regulatory customers to close the gap between medical knowledge and medical practice to improve patients’ lives,” said Rob Kotchie, president, Real World Solutions, IQVIA.

IQVIA现实世界解决方案总裁Rob Kotchie表示：“IQVIA很荣幸能够因其在帮助我们的医疗事务和监管客户弥合医学知识与医疗实践之间的差距以改善患者生活方面所发挥的作用而获得认可。”。

'IQVIA stands out as a prominent service provider distinguished by its wide scope of services and extensive domain expertise, which is further augmented through its collaborations with multiple health authorities,” says Lloyd Fernandes, practice director, Everest Group. “Furthermore, IQVIA is well-poised to cater to enterprises' digitization needs via its suite of technology solutions, including IQVIA RIM Smart, productivity tools for electronic submissions, and IQVIA labeling solutions, enabling enhanced process efficiencies.'.

珠穆朗玛峰集团实践总监劳埃德·费尔南德斯（LloydFernandes）表示：“IQVIA以其广泛的服务范围和广泛的领域专业知识而脱颖而出，是一家杰出的服务提供商，通过与多个卫生部门的合作，这一点得到了进一步加强。”。“此外，IQVIA通过其一套技术解决方案（包括IQVIA RIM Smart、电子提交生产力工具和IQVIA标签解决方案）很好地满足了企业的数字化需求，从而提高了流程效率。”。

To review the report, including details on IQVIA’s Leader status, please click here.

要查看报告，包括IQVIA领导地位的详细信息，请单击此处。

About IQVIA

关于IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources, extensive domain expertise and network of partners.

IQVIA（纽约证券交易所代码：IQV）是全球领先的生命科学行业高级分析、技术解决方案和临床研究服务提供商。IQVIA通过其分析、变革技术、大数据资源、广泛的领域专业知识和合作伙伴网络，在医疗保健的各个方面建立智能连接。

IQVIA Connected Intelligence™ delivers actionable insights and powerful solutions with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 87,000 employees, IQVIA conducts operations in more than 100 countries..

IQVIA Connected Intelligence™以速度和灵活性提供可行的见解和强大的解决方案，使客户能够加速创新医疗的临床开发和商业化，从而改善患者的医疗保健效果。IQVIA拥有约87000名员工，在100多个国家开展业务。。

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes.

IQVIA是保护患者个人隐私的全球领导者。。

IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.

IQVIA的见解和执行能力有助于生物技术、医疗器械和制药公司、医学研究人员、政府机构、付款人和其他医疗保健利益相关者深入了解疾病、人类行为和科学进步，努力推进他们的治愈之路。

To learn more, visit www.iqvia.com..

To learn more, visit www.iqvia.com..